CVSCVS HEALTH Corp

NYSE cvshealth.com


$ 58.38 $ 0.39 (0.67 %)    

Monday, 16-Sep-2024 15:59:59 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 58.37
$ 58.58
$ 58.36 x 100
-- x --
$ 57.91 - $ 58.64
$ 52.18 - $ 80.80
5,111,956
na
73.43B
$ 0.77
$ 10.21
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-07-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-08-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-09-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-16-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-14-2018 12-31-2017 10-K
28 11-06-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-09-2017 12-31-2016 10-K
32 11-08-2016 09-30-2016 10-Q
33 08-02-2016 06-30-2016 10-Q
34 05-03-2016 03-31-2016 10-Q
35 02-09-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 08-04-2015 06-30-2015 10-Q
38 05-01-2015 03-31-2015 10-Q
39 02-10-2015 12-31-2014 10-K
40 11-04-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 walgreens-agrees-to-1068m-settlement-over-alleged-false-billing-claims

Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addres...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-62-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

 paypal-is-a-buy-jim-cramer-says-as-for-rivian-let-it-percolate

PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solu...

 unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

 cvs-shares-are-trading-lower-wednesday-what-you-need-to-know

CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which ...

 teva-announces-80m-settlement-to-baltimore-city-continues-opioid-litigation-against-other-companies

Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated ...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-62-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

 rbc-capital-reiterates-outperform-on-cvs-health-maintains-68-price-target

RBC Capital analyst Ben Hendrix reiterates CVS Health (NYSE:CVS) with a Outperform and maintains $68 price target.

 auto-stocks-abortion-health-care-in-spotlight-at-dnc-joe-biden-uaw-president-women-affected-by-roe-v-wade-decision-headline-night-1

The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION